Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.31 [1.22-1.41],4.21587413801686e-14,trans
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,24,0.94 [0.9-0.98],0.00504687034399834,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,0.95 [0.91-0.99],0.00900681168154078,trans
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,0.96 [0.93-1],0.0260309234241074,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,0.81 [0.68-0.98],0.0267680176708105,trans
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,3,0.91 [0.83-0.99],0.0310486902829268,trans
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,0.8 [0.63-1.01],0.0615539693553648,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,5,0.93 [0.86-1.01],0.0762419030564106,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.14 [0.98-1.31],0.0846857625007314,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,1.09 [0.99-1.2],0.0846857625007314,trans
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,5,1.22 [0.97-1.52],0.0870740576011168,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,10,0.97 [0.93-1.01],0.0925873864860279,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Wald ratio,1,0.96 [0.91-1.01],0.115554536441858,trans
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,I9_PHLETHROMBDVTLOW,Inverse variance weighted,30,1.02 [0.99-1.04],0.140939906367118,trans
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,0.93 [0.83-1.03],0.144402284364522,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,5,0.94 [0.86-1.03],0.202204941705015,trans
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,0.93 [0.83-1.04],0.206051740284145,trans
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.97 [0.93-1.02],0.227259937528442,trans
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Wald ratio,1,0.85 [0.65-1.11],0.236840928144127,trans
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,I9_PHLETHROM,Inverse variance weighted,14,1.02 [0.99-1.04],0.306877492159753,trans
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,25,1.05 [0.95-1.15],0.337842357528775,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,1.01 [0.98-1.05],0.406897967380592,trans
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,0.98 [0.94-1.03],0.418381330266934,trans
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,0.99 [0.96-1.02],0.422126238945559,trans
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,1.08 [0.89-1.32],0.444977290145393,trans
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHERJOINT,Inverse variance weighted,16,1.05 [0.92-1.19],0.463040484578354,trans
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,0.94 [0.79-1.12],0.478921397509252,trans
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,0.94 [0.76-1.16],0.542458544205141,trans
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,14,0.99 [0.95-1.03],0.580426246055411,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Wald ratio,1,0.97 [0.88-1.08],0.611781806688517,trans
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.94 [0.71-1.26],0.698753517376858,trans
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,1.06 [0.79-1.42],0.714118284216481,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,10,0.99 [0.95-1.04],0.770259844090681,trans
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,0.96 [0.71-1.3],0.788739345601219,trans
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,0.98 [0.86-1.13],0.82184209631485,trans
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.99 [0.87-1.12],0.83472705995968,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1 [0.94-1.05],0.863260916180599,trans
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,0.99 [0.92-1.08],0.885003262283943,trans
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,0.99 [0.81-1.21],0.917764417162711,trans
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,1.01 [0.81-1.26],0.929142673955964,trans
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,1 [0.94-1.07],0.955830534342494,trans
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,8,1 [0.95-1.05],0.977950739575649,trans
